Study analysis · Biochimica et biophysica acta · 1979
This hormone makes your liver dump sugar—unless insulin stops it.
When a stress hormone called vasopressin hits a rat’s liver, it releases sugar—but only if the adrenal glands are there and insulin isn’t blocking it.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study is like watching what happens when you drop a drop of juice into a bowl of water in a lab — you see what changes, but you don’t know if it would happen the same way in a real kitchen or if anyone else would see the same thing. It shows a reaction, not a rule.
What’s the bottom line?
When a hormone called vasopressin is added to a rat's liver in a dish, the liver releases more sugar—but only if the adrenal glands are present and insulin isn't around.
How strong is this study?
The experiment was done carefully in a clean lab with a special setup, which is good. But since it’s only in a rat’s liver taken out of the body, and no one was blind to the results, we can’t trust it to tell us what happens in real life. It’s a first step, not the final answer.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
19 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control group+15/15
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
0 / 100
- P-valuesno p-values reported
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 58 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
This design cannot establish causation — the findings describe an association, not a cause. This is an in vitro animal study using perfused rat liver tissue with no randomization, blinding, or control group comparisons that meet criteria for causal inference. It observes physiological responses but cannot rule out confounding factors or establish cause-effect relationships in living organisms.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding statements were disclosed in the provided text, and there is no evidence of industry involvement or author affiliations that suggest bias.
The study appears to be a basic science investigation on vasopressin's metabolic effects in rat liver, published in a reputable journal. No author affiliations with industry, funding disclosures, or conflict of interest statements are present. The absence of such disclosures does not imply conflict, but also prevents full assessment under modern standards.
Key takeaways
- 01
Vasopressin made the liver release more glucose; insulin blocked this effect.
- 02
Removing adrenal glands stopped glucose release, but giving cortisol fixed it.
- 03
No change in fat production.
- 04
Potassium shot up for 2 minutes.
- 05
This suggests vasopressin may help raise blood sugar during stress, but only if other hormones like cortisol are working—and insulin can stop it.
Surprising findings
- Vasopressin’s glucose effect vanished without adrenal glands, but was restored by cortisol alone.Most assume vasopressin directly acts on the liver, but this shows it’s entirely dependent on adrenal hormones—meaning the liver is just the final player in a hormonal relay race.
- Potassium release spiked within 2 minutes—faster than glucose changes.Hormones are usually thought to act through slow metabolic pathways, but this shows vasopressin triggers near-instant ion fluxes, suggesting a direct membrane-level effect.
Practical takeaways
If you're insulin resistant, managing stress alone may not lower blood sugar—your body may need better insulin sensitivity to block vasopressin’s sugar-releasing effect.
This was tested in rat livers in a dish—human physiology involves more hormones, nerves, and feedback loops.
low confidenceWhy this study matters
Vasopressin = Liver Sugar Bomb
Vasopressin triggered a significant increase in glucose release from perfused rat livers under fed conditions, but this effect vanished when insulin was added or when adrenal glands were removed. Cortisol restored glucose release in adrenalectomized rats.
This reveals how stress hormones like vasopressin don’t work alone—they need backup from cortisol and can be shut down by insulin, which explains why stress doesn’t always spike blood sugar in everyone.
Potassium Spike in 2 Minutes
Within just two minutes of vasopressin exposure, the liver released a sudden burst of potassium ions—faster than any metabolic change—suggesting a direct, non-metabolic effect on liver cell ion channels.
This rapid potassium surge hints that vasopressin might trigger immediate cellular changes before affecting metabolism—like a biological alarm bell—opening doors to new understanding of hormone signaling speed.
No Effect on Fat Production
Despite boosting glucose release, vasopressin had zero measurable impact on fatty acid synthesis from glucose or lactate—even when those precursors were abundant in the perfusion medium.
It shows the liver doesn’t just dump everything under stress—it selectively prioritizes glucose over fat production, which could reshape how we think about metabolic flexibility during stress.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
When a hormone called vasopressin is added to a rat's liver in a dish, the liver releases more sugar—but only if the adrenal glands are present and insulin isn't around.
Research results
Vasopressin made the liver release more glucose; insulin blocked this effect. Removing adrenal glands stopped glucose release, but giving cortisol fixed it. No change in fat production. Potassium shot up for 2 minutes.
What this means - more context
This suggests vasopressin may help raise blood sugar during stress, but only if other hormones like cortisol are working—and insulin can stop it.
To determine how vasopressin regulates hepatic glucose and lipid metabolism in perfused rat livers under fed conditions.
Vasopressin stimulates glucose release from perfused rat livers in fed rats, an effect reduced by insulin or adrenal removal. Cortisol restores glucose release in adrenalectomized rats. Vasopressin does not affect fatty acid synthesis from glucose or lactate but causes a transient increase in potassium release within 2 minutes.
Methods Used
Perfused liver preparations from fed rats; experimental manipulations included insulin infusion, adrenal ablation, and in vivo cortisol administration; measurements of glucose release, fatty acid synthesis, and potassium efflux.
Main Finding
Vasopressin increases hepatic glucose production, modulated by insulin and adrenal hormones; no effect on fatty acid synthesis; transient K+ release observed within 2 minutes.
Confidence Level
Moderate; controlled experimental design with clear interventions, but no statistical measures (p-values, effect sizes, or confidence intervals) reported.
Study Flags
Red Flags
- •No statistical measures reported (p-values, effect sizes, confidence intervals)
- •Animal model (rats) with no human data
- •No randomization or blinding described
Surprising Findings
Vasopressin’s glucose effect vanished without adrenal glands, but was restored by cortisol alone.
Most assume vasopressin directly acts on the liver, but this shows it’s entirely dependent on adrenal hormones—meaning the liver is just the final player in a hormonal relay race.
Practical Takeaways
If you're insulin resistant, managing stress alone may not lower blood sugar—your body may need better insulin sensitivity to block vasopressin’s sugar-releasing effect.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 58 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Animal Case-Control
Subject
Lower probability
on the GRADE evidence scale
This study is like watching what happens when you drop a drop of juice into a bowl of water in a lab — you see what changes, but you don’t know if it would happen the same way in a real kitchen or if anyone else would see the same thing. It shows a reaction, not a rule.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Controlled perfusion system allows precise manipulation of hormone concentrations
- Use of specific experimental conditions (fed rats, defined media)
- Clear reporting of observed physiological responses
Weaknesses
- No randomization
- No blinding
- No control group beyond baseline
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
When a hormone called vasopressin is added to a rat's liver in a dish, the liver releases more sugar—but only if the adrenal glands are present and insulin isn't around.
Research results
Vasopressin made the liver release more glucose; insulin blocked this effect. Removing adrenal glands stopped glucose release, but giving cortisol fixed it. No change in fat production. Potassium shot up for 2 minutes.
What this means - more context
This suggests vasopressin may help raise blood sugar during stress, but only if other hormones like cortisol are working—and insulin can stop it.
To determine how vasopressin regulates hepatic glucose and lipid metabolism in perfused rat livers under fed conditions.
Vasopressin stimulates glucose release from perfused rat livers in fed rats, an effect reduced by insulin or adrenal removal. Cortisol restores glucose release in adrenalectomized rats. Vasopressin does not affect fatty acid synthesis from glucose or lactate but causes a transient increase in potassium release within 2 minutes.
Methods Used
Perfused liver preparations from fed rats; experimental manipulations included insulin infusion, adrenal ablation, and in vivo cortisol administration; measurements of glucose release, fatty acid synthesis, and potassium efflux.
Main Finding
Vasopressin increases hepatic glucose production, modulated by insulin and adrenal hormones; no effect on fatty acid synthesis; transient K+ release observed within 2 minutes.
Confidence Level
Moderate; controlled experimental design with clear interventions, but no statistical measures (p-values, effect sizes, or confidence intervals) reported.
Study Flags
Red Flags
- •No statistical measures reported (p-values, effect sizes, confidence intervals)
- •Animal model (rats) with no human data
- •No randomization or blinding described
Surprising Findings
Vasopressin’s glucose effect vanished without adrenal glands, but was restored by cortisol alone.
Most assume vasopressin directly acts on the liver, but this shows it’s entirely dependent on adrenal hormones—meaning the liver is just the final player in a hormonal relay race.
Practical Takeaways
If you're insulin resistant, managing stress alone may not lower blood sugar—your body may need better insulin sensitivity to block vasopressin’s sugar-releasing effect.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 58 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Animal Case-Control
Subject
Lower probability
on the GRADE evidence scale
This study is like watching what happens when you drop a drop of juice into a bowl of water in a lab — you see what changes, but you don’t know if it would happen the same way in a real kitchen or if anyone else would see the same thing. It shows a reaction, not a rule.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Controlled perfusion system allows precise manipulation of hormone concentrations
- Use of specific experimental conditions (fed rats, defined media)
- Clear reporting of observed physiological responses
Weaknesses
- No randomization
- No blinding
- No control group beyond baseline
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The experiment was done carefully in a clean lab with a special setup, which is good. But since it’s only in a rat’s liver taken out of the body, and no one was blind to the results, we can’t trust it to tell us what happens in real life. It’s a first step, not the final answer.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
19 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control group+15/15
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
0 / 100
- P-valuesno p-values reported
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 58 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
This design cannot establish causation — the findings describe an association, not a cause. This is an in vitro animal study using perfused rat liver tissue with no randomization, blinding, or control group comparisons that meet criteria for causal inference. It observes physiological responses but cannot rule out confounding factors or establish cause-effect relationships in living organisms.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding statements were disclosed in the provided text, and there is no evidence of industry involvement or author affiliations that suggest bias.
The study appears to be a basic science investigation on vasopressin's metabolic effects in rat liver, published in a reputable journal. No author affiliations with industry, funding disclosures, or conflict of interest statements are present. The absence of such disclosures does not imply conflict, but also prevents full assessment under modern standards.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Thomas DeLauer cite this study, drawing 1 claim from it.
- Very strong evidence
Randomized or controlled trials support this claim, alongside consistent supporting evidence.
Evidence
Authored by
2 researchersIf this is your work, this is how we attribute it on Fit Body Science. Christopher J. Kirk is listed as the lead author.